10-43120057-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000355710.8(RET):​c.2608-24G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.217 in 1,611,680 control chromosomes in the GnomAD database, including 39,224 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3284 hom., cov: 33)
Exomes 𝑓: 0.22 ( 35940 hom. )

Consequence

RET
ENST00000355710.8 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.305

Publications

20 publications found
Variant links:
Genes affected
RET (HGNC:9967): (ret proto-oncogene) This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]
RET Gene-Disease associations (from GenCC):
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • multiple endocrine neoplasia type 2A
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P
  • multiple endocrine neoplasia type 2B
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Hirschsprung disease, susceptibility to, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Haddad syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hirschsprung disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • bilateral renal agenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 10-43120057-G-A is Benign according to our data. Variant chr10-43120057-G-A is described in ClinVar as Benign. ClinVar VariationId is 24956.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.224 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000355710.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
NM_020975.6
MANE Select
c.2608-24G>A
intron
N/ANP_066124.1
RET
NM_001406743.1
c.2608-24G>A
intron
N/ANP_001393672.1
RET
NM_001406744.1
c.2608-24G>A
intron
N/ANP_001393673.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
ENST00000355710.8
TSL:5 MANE Select
c.2608-24G>A
intron
N/AENSP00000347942.3
RET
ENST00000340058.6
TSL:1
c.2608-24G>A
intron
N/AENSP00000344798.4
RET
ENST00000713926.1
c.2344-24G>A
intron
N/AENSP00000519223.1

Frequencies

GnomAD3 genomes
AF:
0.202
AC:
30780
AN:
152050
Hom.:
3272
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.150
Gnomad AMI
AF:
0.246
Gnomad AMR
AF:
0.193
Gnomad ASJ
AF:
0.121
Gnomad EAS
AF:
0.231
Gnomad SAS
AF:
0.158
Gnomad FIN
AF:
0.293
Gnomad MID
AF:
0.185
Gnomad NFE
AF:
0.227
Gnomad OTH
AF:
0.192
GnomAD2 exomes
AF:
0.204
AC:
50418
AN:
247006
AF XY:
0.204
show subpopulations
Gnomad AFR exome
AF:
0.150
Gnomad AMR exome
AF:
0.153
Gnomad ASJ exome
AF:
0.124
Gnomad EAS exome
AF:
0.233
Gnomad FIN exome
AF:
0.289
Gnomad NFE exome
AF:
0.226
Gnomad OTH exome
AF:
0.197
GnomAD4 exome
AF:
0.219
AC:
319375
AN:
1459512
Hom.:
35940
Cov.:
37
AF XY:
0.217
AC XY:
157520
AN XY:
725856
show subpopulations
African (AFR)
AF:
0.141
AC:
4716
AN:
33430
American (AMR)
AF:
0.156
AC:
6934
AN:
44516
Ashkenazi Jewish (ASJ)
AF:
0.121
AC:
3161
AN:
26072
East Asian (EAS)
AF:
0.215
AC:
8518
AN:
39652
South Asian (SAS)
AF:
0.162
AC:
13896
AN:
85872
European-Finnish (FIN)
AF:
0.278
AC:
14788
AN:
53152
Middle Eastern (MID)
AF:
0.178
AC:
969
AN:
5442
European-Non Finnish (NFE)
AF:
0.228
AC:
253855
AN:
1111084
Other (OTH)
AF:
0.208
AC:
12538
AN:
60292
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
13628
27256
40885
54513
68141
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8576
17152
25728
34304
42880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.203
AC:
30818
AN:
152168
Hom.:
3284
Cov.:
33
AF XY:
0.206
AC XY:
15282
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.150
AC:
6229
AN:
41542
American (AMR)
AF:
0.193
AC:
2955
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.121
AC:
420
AN:
3468
East Asian (EAS)
AF:
0.231
AC:
1190
AN:
5158
South Asian (SAS)
AF:
0.158
AC:
760
AN:
4820
European-Finnish (FIN)
AF:
0.293
AC:
3103
AN:
10578
Middle Eastern (MID)
AF:
0.192
AC:
56
AN:
292
European-Non Finnish (NFE)
AF:
0.227
AC:
15462
AN:
67982
Other (OTH)
AF:
0.198
AC:
419
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1307
2614
3922
5229
6536
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
332
664
996
1328
1660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.209
Hom.:
5364
Bravo
AF:
0.193
Asia WGS
AF:
0.187
AC:
653
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
not provided (2)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
Multiple endocrine neoplasia type 2B (1)
-
-
1
Multiple endocrine neoplasia, type 2 (1)
-
-
1
Pheochromocytoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
5.0
DANN
Benign
0.74
PhyloP100
-0.30
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2472737; hg19: chr10-43615505; COSMIC: COSV60686346; API